There were 449 press releases posted in the last 24 hours and 206,531 in the last 365 days.

Retinal Disorder Treatment Market Report 2021-2031: Visiongain Research Inc.

/EIN News/ -- Visiongain has published a new report on Retinal Disorder Treatment Market Report from 2021-2031: Forecasts By Disease Indication (Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema, Retinal Vein Occlusion, and Others), By Therapeutic Class (Anti-VEGF Agents, Anti-inflammatory Drugs, and Others), By Dosage Form (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments, and Others), By Patient Demographics (Adults, Geriatric, and Pediatric), By End User (Hospitals, Homecare, Specialty Clinics, and Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies) PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS, COVID-19 Recovery Scenarios.

COVID-19 Impact on Retinal Disorder Treatment Market
COVID-19 impact through different recovery models such as V-shaped, U-shaped, W-shaped, and L-shaped; has been taken into consideration while estimating and forecasting the Retinal Disorder Treatment market. Different recovery scenarios are also included in the report for all the segments and regions/nation. The recovery scenarios based on which market has been forecasted and analyzed herein the report are mentioned below:

Download Exclusive Sample of Report @ https://www.visiongain.com/report/retinal-disorder-market-2021/#download_sampe_div

Market Drivers
Increasing Prevalence of Retinal Disorders
Retinal Disorders prevalence has increased very rapidly as compared to the last few years and it is expected that retinal disorders prevalence will increase during the forecast period. According to Genentech, USA Inc. that approximately 200,000 new cases of Wet Age-Related Macular Degeneration (Wet AMD) use to be identified each year in the United States and approximately 7.7 million Americans are suffering from diabetic retinopathy. And which is expected to increase by 11.3 million by 2030. Increasing retinal disorders cases is creating a huge demand for the retinal disorders treatment. Due to which Increasing prevalence of retinal disorders is working as a driver for the retinal disorders treatment market.

Increasing Geriatric Population around the World
An increasing in geriatric population is suffering from various retinal disorders including diabetic retinopathy and age-related degeneration (AMD). All regions are facing a huge increase in the number of geriatric populations. For instance: According to the United Nations, Department of Economic and Social Affairs, the Population Division geriatric population (persons aged 65 or over) was 702.9 million in 2019. Geriatric population is at high risk of retinal disorders and requires anti-VEGF agents, anti-inflammatory drugs, and others for treatment. Rapid increase in the number of the geriatric population around the globe is also increasing demand for retinal disorders treatment around the world.

Market Opportunities

Increasing Strategic initiatives in retinal disorders treatment Drugs
Manufactures present in the market are taking various strategic initiatives in order to increase their revenue generation in the market, strategic initiatives such as mergers & acquisitions, product launches and press conference & events. These strategic initiatives are helping manufacturers in the market to increase their revenue generation due to this reason increasing strategic initiatives in the retinal disorders treatment market is creating new opportunities as a driver for the retinal disorders treatment market.

Get Detailed TOC @ https://www.visiongain.com/report/retinal-disorder-market-2021/#download_sampe_div

How the Retinal Disorder Treatment Market report helps you
In summary, our 250+ page report provides you with the following knowledge:

  • Revenue forecasts to 2031 for Retinal Disorder Treatment Market, with forecasts for Get our report today Retinal Disorder Treatment Market Forecast 2021-2031: By Disease Indication, Therapeutic Class, Dosage Form, Patient Demographics, End User, Distribution Channel and Leading Regional/ Country market analysis each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Retinal Disorder Treatment market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Retinal Disorder Treatment Market.

Competitive Landscape

Top companies (Santen Pharmaceutical Co., Ltd., Regeneron Pharmaceuticals, Inc., and F. Hoffmann-La Roche Ltd.) constitute more than XX% share of the global Retinal Disorder Treatment market. Other companies profiled in the report include Pfizer, Inc., Allergan plc, Shire (Takeda Pharmaceutical Company Limited), Bayer AG, Graybug Vision, Inc., Novartis AG and Acucela Inc. (Kubota Pharmaceutical Holdings Co., Ltd.). Some of the key developments are listed below:

In 2020, Ocugen has received fourth Orphan Drug Designation (ODD) from FDA granted for OCU400 in the treatment of PDE6B gene mutation-associated retinal diseases. The launch will help the company to expand retinal disorder treatment and widened revenue generation from market focused product portfolio.

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

To access the data contained in this document please email contactus@visiongain.com

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain’s study is for everybody needing commercial analyses for the Retinal Disorder Treatment Market and leading companies. Here you will find data, trends and predictions. Please order our report now.

Find more Visiongain research reports on Therapeutic Drugs Sector click on the following links:

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

About Visiongain

Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports mean that you can have a bespoke piece of market intelligence customized to your very own business needs. 

Contact:

Sara Peerun
Commercial Director
Visiongain Inc.
Tel: + 44 207 549 9987
USA Tel: 00 1 718 682 4567
EU Tel: 00 353 1 695 0006
Email: sara.peerun@visiongain.com
Web: https://www.visiongain.com/
Follow Us: LinkedIn | Twitter

-

SOURCE Visiongain Limited.


Primary Logo